Systemic mastocytosis with associated hematologic neoplasm

What it is

From: Orphanet

An advanced form of systemic mastocytosis (SM) characterized by the abnormal accumulation of neoplastic mast cells (MCs) in one or more extracutaneous organs, mainly the bone marrow, associated with another hematologic neoplasm of non MC nature.

Reported clinical features and what the terms mean

The following findings are associated with this condition in Orphanet. They are not a checklist for diagnosing yourself, and they do not all occur in every affected person. Some are examination, imaging or laboratory findings that cannot be recognised at home.

The frequency labels describe how often a finding was reported among people with the condition in the source. They do not give the chance that a person with that symptom has the condition. Definitions below reproduce HPO terminology; they explain the term, not the likely severity in an individual.

Abnormal mast cell morphology · Very frequent (99-80%)

Any structural anomaly of mast cells, which are found in almost all tissues and contain numerous basophilic granules and are capable of releasing large amounts of histamine and heparin upon activation.

Hematological neoplasm · Very frequent (99-80%)

Neoplasms located in the blood and blood-forming tissue (the bone marrow and lymphatic tissue).

Increased serum mast cell beta-tryptase concentration · Very frequent (99-80%)

An abnormally elevated concentration of total tryptase (alpha and beta tryptase) in the blood circulation.

Myeloid leukemia · Very frequent (99-80%)

A leukemia that originates from a myeloid cell, that is the blood forming cells of the bone marrow.

Bone marrow hypercellularity · Frequent (79-30%)

A larger than normal amount or percentage of hematopoietic cells relative to marrow fat.

Fatigue · Frequent (79-30%)

A subjective feeling of tiredness characterized by a lack of energy and motivation.

Fever · Frequent (79-30%)

Body temperature elevated above the normal range.

Headache · Frequent (79-30%)

Cephalgia, or pain sensed in various parts of the head, not confined to the area of distribution of any nerve.

Increased total eosinophil count · Frequent (79-30%)

Increased count of eosinophils in the blood.

Increased total leukocyte count · Frequent (79-30%)

An abnormal increase in the number of leukocytes in the blood.

Myeloproliferative disorder · Frequent (79-30%)

Proliferation (excess production) of hemopoietically active tissue or of tissue which has embryonic hemopoietic potential.

Normocytic anemia · Frequent (79-30%)

A kind of anemia in which the volume of the red blood cells is normal.

Pallor · Frequent (79-30%)

Abnormally pale skin.

Pruritus · Frequent (79-30%)

Pruritus is an itch or a sensation that makes a person want to scratch. This term refers to an abnormally increased disposition to experience pruritus.

Other findings in the same source

From: Orphanet

Additional reported features include Thrombocytopenia (Frequent (79-30%)); Weight loss (Frequent (79-30%)); Normochromic anemia (Frequent (79-30%)); Abdominal pain (Occasional (29-5%)); Abnormality of the respiratory system (Occasional (29-5%)); Acute myeloid leukemia (Occasional (29-5%)); Arthralgia (Occasional (29-5%)); Bone pain (Occasional (29-5%)); Chronic myelomonocytic leukemia (Occasional (29-5%)); Diarrhea (Occasional (29-5%)). This is a selected summary, not a complete description of the condition.

When it may begin

From: Orphanet

Adult; Elderly

Inheritance in the source

From: Orphanet

Not applicable

Frequency and the population described

From: Orphanet

Point prevalence: 1-9 / 100 000; Europe; Class only.

Which doctor should you see?

The suggested department for discussing Systemic mastocytosis with associated hematologic neoplasm is Oncology, with a oncologist and relevant organ specialist as the relevant type of clinician. General physician / Family Medicine; paediatrician for children. Referral depends on symptoms.

Additional services that may be relevant, depending on the findings, include: Clinical Genetics; Relevant organ specialist / Surgical Oncology as indicated.

This is an editorial referral starting point. The appropriate clinic depends on the person’s age, symptoms, previous diagnosis and local services. The first clinician can decide whether another specialty or a team is needed; a department label does not confirm the diagnosis.

How to prepare for an assessment

Bring a short timeline of the main symptoms: when they first appeared, whether they are constant or episodic, what seems to change them, and how they affect daily activities. Include previous reports, discharge summaries, current medicines and supplements, allergies, and any relevant family history. A dated record is more useful than trying to match every feature in an online article.

Ask the clinician what is already established and what remains uncertain. If a test is suggested, ask what question it answers, what its limitations are and how the result would change the next step. The information here is not an instruction to arrange every possible test. In children, bring growth, developmental and school information if it is relevant to the concern.

• Has the exact tumour type been confirmed, and is staging relevant?
• What is the goal of each proposed treatment option?
• How will side effects, daily function and supportive care be addressed?

Treatment discussions and follow-up

The material gathered for this draft does not provide a complete condition-specific treatment pathway for Systemic mastocytosis with associated hematologic neoplasm. That gap does not mean that treatment is unavailable. A clinician needs to establish the diagnosis and review current guidance before recommending medicines, procedures, rehabilitation or other support.

Before leaving the appointment, clarify the next review date, who will communicate results, and whom to contact if the situation changes. Discuss difficulties with sleep, work, school, mobility, eating or emotional wellbeing when these are relevant. Practical support may require coordination between the treating clinician and other services.

The collected references do not establish a complete prevention or long-term outlook section for this entry. Missing information should not be interpreted as proof that prevention is impossible or that a particular outcome is inevitable. Ask what is known for the exact subtype, stage and personal circumstances, and which uncertainties remain.

When to seek emergency help

Severe breathing difficulty, collapse, new stroke-like symptoms, a seizure that is prolonged or repeated without recovery, uncontrolled major bleeding, or an immediate risk of self-harm require emergency help. In India, call 112 or reach the nearest emergency department. This is a general, non-exhaustive warning list; it is not a condition-specific triage tool.